001328.SZ
登康口腔
SZSE · C 制造业 · CN
CNY 27.96
−1.55%Year over year
Reported trailing growth
- Revenue
- +9.3%
- EBITDA
- —
- EBIT
- +10.6%
- EPS
- +13.2%
- Free cash flow
- +22.6%
- Operating cash flow
- +2.6%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +9.3%
- EBITDA
- +13.6%
- EBIT
- +12.4%
- Net income
- +10.4%
- EPS
- +0.3%
- Free cash flow
- +80.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026